Pharmacies incorporate digital sleep analysis as part of recommendations to customers looking for solutions to sleep issues.
Leaders in digital sleep analysis, Cerebra are pleased to announce a new partnership with Rubicon pharmacies. This partnership showcases the importance of understanding the impact of sleep when it comes to our overall health and well-being. New partnership expands western Canadians’ access to in-depth sleep analysis in the comfort of their own homes.
Cerebra’s treatment partner network and direct-to-home delivery model is bolstered by its Sleep Advocate program, which enables pharmacists, dentists and other healthcare providers to offer their patients access to an effective and affordable sleep program through the Cerebra Sleep Study. Initially established in Manitoba, the Advocate program will expand into all of western Canada through Rubicon Pharmacies. With over 105 locations in Western Canada, and many in rural regions, this partnership will provide direct accessibility to Cerebra’s at-home sleep study service. Rubicon helps support independent pharmacies with a focus on personalized health for their customers, including proper testing, consultations and medical reviews. This further supports Cerebra’s goal to ensure people receive the sleep solutions that are right for them.
“We know getting a good quality sleep plays a significant role in optimizing physical and mental health as well as quality of life, explains Dawson Reimer, Cerebra CEO. “Our partnership with Rubicon will help more Canadians have access to understanding the unique qualities of their sleep and their sleep issues to help them get on the right path to better sleep.”
Cerebra’s in-home study is available for purchase in western Canada at www.cerebra.health and through the Company’s clinical and retail partners.
For more information or to schedule an interview contact:
Mary Fearon or Lindsay Glasspoole
email@example.com / firstname.lastname@example.org
Cerebra Health Inc. (Cerebra) is a Manitoba-based, digital health company focused on improving access to advanced digital sleep analysis and diagnostic technology for the assessment of sleep and the diagnosis of sleep disorders.
Cerebra Medical, a wholly owned subsidiary of Cerebra Health, operates an ISO 13485:2016 certified Quality Management System for the design, development and manufacture of EEG sleep monitoring systems and medical device software for collection and analysis of physiological data recorded during sleep. Cerebra Medical holds an MDSAP certificate in conformance with the requirements of Health Canada and FDA.
Cerebra digital sleep analysis provides unmatched capabilities for in-home sleep analysis, with a focus on improved user experience, state-of-the-art technology, and increased operational efficiency. Cerebra is also working in partnership with leading sleep scientists and researchers to revolutionize clinical sleep medicine by leveraging its core capabilities in digital sleep analysis.